These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death. Sanghera R; Sanders R; Husby M; Bentsen JG Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791 [TBL] [Abstract][Full Text] [Related]
3. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?]. Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995 [TBL] [Abstract][Full Text] [Related]
4. Subcutaneous implantable cardioverter defibrillator in a patient with pectus excavatum. Hamoud A; Barry J Pacing Clin Electrophysiol; 2013 May; 36(5):e138-9. PubMed ID: 22554273 [TBL] [Abstract][Full Text] [Related]
5. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions. Verma N; Rhyner J; Knight BP Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601 [TBL] [Abstract][Full Text] [Related]
6. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation? Randles DA; Hawkins NM; Shaw M; Patwala AY; Pettit SJ; Wright DJ Europace; 2014 Jul; 16(7):1015-21. PubMed ID: 24351884 [TBL] [Abstract][Full Text] [Related]
7. Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing. Poole JE; Gold MR Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1236-44; discussion 1244-5. PubMed ID: 24347599 [No Abstract] [Full Text] [Related]
10. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU; Goldenberg I; Moss AJ Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691 [TBL] [Abstract][Full Text] [Related]
13. Subcutaneous implantable cardioverter defibrillator: Can it overtake its transvenous counterpart. Savarimuthu S; Roy S; Obeidat M; Harky A Pacing Clin Electrophysiol; 2021 Aug; 44(8):1413-1420. PubMed ID: 33878197 [TBL] [Abstract][Full Text] [Related]
14. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator. Sinha SK; Mehta D; Gomes JA Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255 [TBL] [Abstract][Full Text] [Related]
15. The subcutaneous defibrillator: a review of the literature. Aziz S; Leon AR; El-Chami MF J Am Coll Cardiol; 2014 Apr; 63(15):1473-9. PubMed ID: 24530663 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258 [TBL] [Abstract][Full Text] [Related]
17. The subcutaneous implantable cardioverter-defibrillator in review. Kamp NJ; Al-Khatib SM Am Heart J; 2019 Nov; 217():131-139. PubMed ID: 31654943 [TBL] [Abstract][Full Text] [Related]